「fortherepublic of kiribati」の検索結果
133件：121～125件目を表示
-
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
Communications with Customers and Provision of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Cente...
https://www.senju.co.jp/english/about/csr01.html -
acturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibiti...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
6, 2026 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
6, 2026 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
鹿 哲 也＊1、内 野 美 樹＊2 ＊1 千寿製薬株式会社 研究開発本部 メディカルアフェアーズ部 ＊2 ケイシン五反田アイクリニック 医学と薬学, 83(1) 1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in...
https://www.senju.co.jp/rd/thesis/